A Prospective Single-Arm Study（NCLDR）

NCT07028918 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Oral Squamous Cell Carcinoma (OSCC)

Interventions

RADIATION: Low dose radiotherapy regimen
DRUG: New adjuvant immunotherapy regimen
PROCEDURE: Surgical treatment
DRUG: Postoperative adjuvant therapy plan
RADIATION: Radical radiotherapy plan

Sponsor

Qilu Hospital of Shandong University